4.7 Article

Group A Streptococcus Strains Circulating during Scarlet Fever Epidemic, Beijing, China, 2011

Journal

EMERGING INFECTIOUS DISEASES
Volume 19, Issue 6, Pages 909-915

Publisher

CENTERS DISEASE CONTROL
DOI: 10.3201/eid1906.121020

Keywords

-

Funding

  1. Beijing Nova Program of the Beijing Science and Technology Commission [2011047]
  2. National Key Program for Infectious Disease of China [2012ZX10004215-003-001]

Ask authors/readers for more resources

Scarlet fever is one of a variety of diseases caused by group A Streptococcus (GAS). During 2011, a scarlet fever epidemic characterized by peak monthly incidence rates 2.9-6.7 times higher than those in 2006-2010 occurred in Beijing, China. During the epidemic, hospital-based enhanced surveillance for scarlet fever and pharyngitis was conducted to determine characteristics of circulating GAS strains. The surveillance identified 3,359 clinical cases of scarlet fever or pharyngitis. GAS was isolated from 647 of the patients; 76.4% of the strains were type emm12, and 17.1% were emm1. Almost all isolates harbored superantigens speC and ssa. All isolates were susceptible to penicillin, and resistance rates were 96.1% to erythromycin, 93.7% to tetracycline, and 79.4% to clindamycin. Because emm12 type GAS is not the predominant type in other countries, wider surveillance for the possible spread of emm12 type GAS from China to other countries is warranted.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available